HomeInsightsStock Comparison

Accretion Pharmaceuticals Ltd vs Novartis India Ltd Stock Comparison

Accretion Pharmaceuticals Ltd vs Novartis India Ltd Stock Comparison

Last Updated on: May 27, 2025

Key Highlights

  • The Latest Trading Price of Accretion Pharmaceuticals Ltd is ₹ 67.6 as of 27 May 15:30.
  • The P/E Ratio of Accretion Pharmaceuticals Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Novartis India Ltd changed from 123.1 on March 2020 to 29.8 on March 2024 . This represents a CAGR of -24.70% over 5 years.
  • The Market Cap of Accretion Pharmaceuticals Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Novartis India Ltd changed from ₹ 1240 crore on March 2020 to ₹ 2539 crore on March 2024 . This represents a CAGR of 15.41% over 5 years.
  • The revenue of Accretion Pharmaceuticals Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Novartis India Ltd for the Mar '25 is ₹ 94.51 crore as compare to the Dec '24 revenue of ₹ 103.6 crore. This represent the decline of -8.77%.
  • The ebitda of Accretion Pharmaceuticals Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Novartis India Ltd for the Mar '25 is ₹ 34.54 crore as compare to the Dec '24 ebitda of ₹ 36.18 crore. This represent the decline of -4.53%.
  • The net profit of Accretion Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Novartis India Ltd changed from ₹ 20.26 crore to ₹ 29.3 crore over 8 quarters. This represents a CAGR of 20.26% .
  • The Dividend Payout of Accretion Pharmaceuticals Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Novartis India Ltd changed from 244.84 % on March 2020 to 72.43 % on March 2024 . This represents a CAGR of -21.62% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Accretion Pharmaceuticals Ltd

  • Accretion Pharmaceuticals was incorporated in year 2012, the Promoters Mr. Harshad Nanubhai Rathod, Mr. Vivek Ashok Kumar Patel, Mr. Mayur Popatlal Sojitra and Mr. Hardik Mukundbhai Prajapati, came together to establish a pharmaceutical manufacturing unit, to provide health care products.
  • Thus, the foundation of 'Accretion Pharmaceuticals' was laid down, which was started as a Partnership Firm in the name of 'M/s Accretion Pharmaceuticals', pursuant to a deed of partnership dated December 18, 2012. The manufacturing facility which is currently located at Ahmedabad, in Sanand District of Gujarat, commenced its manufacturing operations in year 2014.
  • Thereafter, the Partnership Firm was converted into a Limited Company in the name of 'Accretion Pharmaceuticals Limited' and a certificate of incorporation dated November 29, 2023 was issued by the Registrar of Companies, Central Registration Centre, for and on behalf of the jurisdictional Registrar of Companies.

About Novartis India Ltd

  • Novartis India Limited (NIL) is a subsidiary of Swiss giant Novartis, the world's second largest pharmaceutical company was incorporated on 13 December 1947.
  • The Company is engaged in manufacturing and marketing of drugs, pharmaceutical products and formulations for consumer healthcare and animal healthcare; it operates into four segments such as Pharmaceuticals, Generics, Over the Trade Counter and Animal Health. The origin of Novartis is linked to the origin of three distinct companies namely Geigy, Ciba, and Sandoz.
  • The history of Geigy goes back to the middle of the 18th century, Ciba was founded around 1860, and Sandoz was set-up in 1886.
  • In 1970 Ciba and Geigy merged to form Ciba-Geigy Ltd. Sandoz and Ciba-Geigy Ltd continued as separate entities for the next 25 years.
  • In 1996, in one of the largest corporate mergers in history Sandoz and Ciba-Geigy Ltd.

Accretion Pharmaceuticals Ltd News Hub

News

NSE SME Accretion Pharma stumbles on market debut

The scrip was listed at 79, a discount of 21.78% over the initial public offer (IPO) price...

Read more

21 May 2025 10:38

News

NSE SME Accretion Pharmaceuticals' IPO ends with subscription of 7.31 times

The initial public offer (IPO) of Accretion Pharmaceuticals received bids for 2,00,06,400 ...

Read more

19 May 2025 11:43

Novartis India Ltd News Hub

News

Novartis India schedules AGM

Novartis India announced that the 77th Annual General Meeting(AGM) of the company will be ...

Read more

10 May 2025 09:38

News

Board of Novartis India recommends final dividend

Novartis India announced that the Board of Directors of the Company at its meeting held on...

Read more

10 May 2025 09:38

News

Novartis India to announce Quarterly Result

Novartis India will hold a meeting of the Board of Directors of the Company on 9 May 2025....

Read more

28 Mar 2025 09:32

News

Novartis India to hold board meeting

Novartis India will hold a meeting of the Board of Directors of the Company on 28 January ...

Read more

28 Dec 2024 09:37

News

Novartis India schedules board meeting

Novartis India will hold a meeting of the Board of Directors of the Company on 25 October ...

Read more

28 Sep 2024 10:07

News

Novartis India to declare Quarterly Result

Novartis India will hold a meeting of the Board of Directors of the Company on 29 July 202...

Read more

28 Jun 2024 17:50

SWOT Analysis Of Novartis India Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Novartis India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of null and Novartis India Ltd

Which company has a larger market capitalization, Accretion Pharmaceuticals Ltd or Novartis India Ltd?

Market cap of Accretion Pharmaceuticals Ltd is 75 Cr while Market cap of Novartis India Ltd is 2,670 Cr

What are the key factors driving the stock performance of Accretion Pharmaceuticals Ltd and Novartis India Ltd?

The stock performance of Accretion Pharmaceuticals Ltd and Novartis India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Accretion Pharmaceuticals Ltd and Novartis India Ltd?

As of May 27, 2025, the Accretion Pharmaceuticals Ltd stock price is INR ₹67.6. On the other hand, Novartis India Ltd stock price is INR ₹1081.55.

How do dividend payouts of Accretion Pharmaceuticals Ltd and Novartis India Ltd compare?

To compare the dividend payouts of Accretion Pharmaceuticals Ltd and Novartis India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions